Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM Medical Education on ReachMD

Name: Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
Uploaded: 2022-05-03T04:00:00+00:00
Duration: 4 min 36 s
Description: Dr. Milind Desai discusses the design and results of the VALOR-HCM trial, which demonstrated that mavacamten reduced the need for septal reduction therapy